Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.55 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.53 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | MPL | P40238 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dobesilic Acid SCHEMBL29389625 | 0.98 | LMNA (0.72) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL232087 | 0.98 | LMNA (0.72) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL344443 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL15364076 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL9790423 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL78224 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL370202 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL866670 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL10589964 | 0.95 | HSD17B10 (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL78222 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116589673-A | Flame-retardant hydrogenated bisphenol A polycarbonate and preparation method thereof | 四川轻化工大学 | 2023-08-15 | — | — | CN | claimed |
| CN-115403740-A | Biodegradable carbon dioxide-based polyurethane resin and preparation method thereof | 聚源化学工业股份有限公司 | 2022-11-29 | — | — | CN | claimed |
| CN-111479913-B | Compositions containing lanthanide metal complexes | 罗地亚经营管理公司 | 2021-12-21 | — | — | CN | claimed |
| US-20210179975-A1 | COMPOSITION CONTAINING LANTHANIDE METAL COMPLEX | SPECIALTY OPERATIONS FRANCE (FR) | 2021-06-17 | — | — | US | claimed |
| CN-112848582-A | Bionic material and preparation method thereof | 深圳第三代半导体研究院 | 2021-05-28 | — | — | CN | claimed |
| CN-112266456-A | Biodegradable carbon dioxide-based polyurethane elastomer and preparation method thereof | 中国科学院长春应用化学研究所 | 2021-01-26 | — | — | CN | claimed |
| CN-111479913-A | Compositions containing lanthanide metal complexes | 罗地亚经营管理公司 | 2020-07-31 | — | — | CN | claimed |
| US-20170231932-A1 | METHODS OF USE FOR 2,5-DIHYDROXYBENZENE SULFONIC ACID COMPOUNDS FOR THE TREATMENT OF CANCER, ROSACEA AND PSORIASIS | AmDerma Pharmaceuticals, LLC | 2017-08-17 | — | — | US | claimed |
| US-9610256-B2 | Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer | AmDerma Pharmaceuticals, LLC (US) | 2017-04-04 | — | — | US | claimed |
| US-9301931-B2 | Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis | AmDerma Pharmaceuticals, LLC (US) | 2016-04-05 | — | — | US | claimed |
| US-20160058719-A1 | Methods Of Use For 2,5-Dihydroxybenzene Sulfonic Acid Compounds For The Treatment Of Cancer, Rosacea And Psoriasis | Lichten, Edward | 2016-03-03 | — | — | US | claimed |
| US-20150065584-A1 | Methods Of Use For 2,5-Dihydroxybenzene Sulfonic Acid Compounds For The Treatment Of Cancer, Rosacea And Psoriasis | AmDerma Pharmaceuticals, LLC | 2015-03-05 | — | — | US | claimed |
| US-8912171-B2 | Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis | AmDerma Pharmaceuticals, LLC (US) | 2014-12-16 | — | — | US | claimed |
| US-20130296282-A1 | Methods Of Use For 2,5-Dihydroxybenzene Sulfonic Acid Compounds For The Treatment Of Cancer, Rosacea And Psoriasis | AmDerma Pharmaceuticals, LLC | 2013-11-07 | — | — | US | claimed |
| WO-2004108414-A2 | LITHOGRAPHIC PRINTING PLATE SYSTEM AND METHOD FOR MANUFACTURING THE PLATE SYSTEM | DIGITAL MIND S.R.L. (IT) | 2004-12-16 | — | — | WO | claimed |
| EP-0203468-B1 | IMPROVED PHOTOGRAPHIC MATERIAL FOR TANNING DEVELOPMENT AND METHOD FOR OBTAINING A RELIEF IMAGE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-03-08 | — | — | EP | claimed |
| US-4737441-A | INCLUDING TWO DIFFERENT SUBSTITUTED 1,4-DIHYDRONBENZENES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-04-12 | — | — | US | claimed |
| EP-0203468-A2 | Improved photographic material for tanning development and method for obtaining a relief image | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1986-12-03 | — | — | EP | claimed |
| US-11807023-B2 | Pretreatment liquid, ink set, image recorded material, base material for image recording, method of producing base material for image recording, and image recording method | FUJIFILM CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-3954767-A | HYPOCHOLESTEROLEMIC, HYPOTRIGLYCIDEMIC AND HYPOLIPIDEMIC ACTIVITY | PROVESAN SA, 19, RUE DE LA CROIX D'OR, GENEVA, SWITZERLAND, A SWISS CORP. | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160058719-A1 | Methods Of Use For 2,5-Dihydroxybenzene Sulfonic Acid Compounds For The Treatment Of Cancer, Rosacea And Psoriasis | IL2, IL2RA, IL5 | LMNA 4181/4885HSD17B10 1497/4885HPGD 2149/4885 |
| US-20150065584-A1 | Methods Of Use For 2,5-Dihydroxybenzene Sulfonic Acid Compounds For The Treatment Of Cancer, Rosacea And Psoriasis | IL2, IL2RA, IL5 | LMNA 4181/4885HSD17B10 1497/4885HPGD 2149/4885 |
| US-20170231932-A1 | METHODS OF USE FOR 2,5-DIHYDROXYBENZENE SULFONIC ACID COMPOUNDS FOR THE TREATMENT OF CANCER, ROSACEA AND PSORIASIS | IL2, IL2RA, IL5 | LMNA 4181/4885HSD17B10 1497/4885HPGD 2149/4885 |
| US-20130296282-A1 | Methods Of Use For 2,5-Dihydroxybenzene Sulfonic Acid Compounds For The Treatment Of Cancer, Rosacea And Psoriasis | IL2, IL2RA, IL5 | LMNA 4181/4885HSD17B10 1497/4885HPGD 2149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.